Acs Fall 2024 Vvd-130037 Vvd1300373. Vividion therapeutics starts phase i clinical trial in advanced solid tumors with keap1 activator. Other proteins may have a lower specific.
Choose from thousands of presentations, network, attend courses and visit the expo. Vividion therapeutics starts phase i clinical trial in advanced solid tumors with keap1 activator.
Acs Fall 2024 Vvd-130037 Vvd1300373 Images References :
